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The aim of this study was to assess the hormonal alterations Ihat may mediate 
the systemic hype"ension that develops In patients during Ihe perloperatlve 
period of orthotopic liver transplantation. We studied nine pediatric patients 
without previous hype"ensiOn or renal disease during six time polntl, starting 
before transplantation and ending at '" hours atter surgery, Hype"ension 
developed In all patients In association with central venous pressures <10 mm 
Hg. fr .. water clearance was negative In all nine patlentl. Vasopressin levels 
increased Intraoperatively but fen as hypertension developed. Atrial natriuret-
ic factor levell Increased as systemic blood pressure rose. A high level of 
plasma renin activity was observed In four patlentl with renallnsutftclency. In 
six patients, postoperative O~our urinary norepinephrine excretion was within 
the normal age-odJusted range. These findings suggest that Ihe combination of 
cyclosporlne, corticosteroids, and, In some patients, an elevated plasma renin 
activity prevents the kidney 'rom responding to the acute volume and salt 
overload .wlth an appropriate diuresis and natriuresis, thus leading to systemic 
hype"enslon. The treatment of hypertension after liver transplantation may 
Include salt restriction, diuretics, and, In thOle patients with a low creatinine 
excretion Index, angiotensin cove"lng enzyme Inhibitors. (J PmATl1989;115:372-
9) 
Systemic hypertension complicates the intraoperative and 
postoperative Ctlune of more than 80C1 of children 
undergoing ortbotopic liver transplantatiollKl~ This hyper-
tension typically develops after hepatic: artery IJWtomosis. 
is sustained for months. and often is severe, lcadin. to 
increased morbidity! The attempt to control such hyper-
tension has had unpredictable resulu and has had only 
limited suc:c:ess despite the use of antihypertensive 
alenu. I" Severe: byperteftJion has been reponed to occur 
during pediatric orthotopic liver transplantation before 
c:yclosporine was used as pan of tbe immunosuppressive 
regimen.' but because of the nearly 30-fold increase in the 
risk of hypertcnsion with tbe use of c:yclosporine. as 
compared with otber immunosuppressive agenu.' attention 
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has focused on the effects of this asent in ailerins salt and 
water balance and in inc:reasinl vascular lone. thcrcb~i 
produc:1nS hYJlCrtension. The mechanisms responsible for 
the development of hYJ)ertension in patienu treated wilh 
· •• /j,,/(' II ~ 
'IImbcrj 
cyclosporine remain poorly understood"" despite several 
studies examining the role of the renin-angiotensin-
aldosterone system.II.1) prostaglandin excretion.'• and the 
sympathetic netv':'us system." 
The purpose of this study was to determine how the 
"hysiologic mechanisms that normally maintain blood 
pressure and tissue perfusion respond to the immediate 
strcsscs of liver transplantation. and how these responses 
relate to the development of hypertension. Such under-
standing may result in more rational and effective treat-
ment of postoperative hypertension. 
~bqelap 
~ine consecutive patienu aged 2 to 16 years were 
studied prospectively during and after primary orthotopic 
liver transplantation. The study was approved by the 
hospital's human righu committee and appropriate con-
sent was obtained. The preoperative diagnoses were biliary 
atresia (three patienu), non-A. non-S hepatitis. cirrhosis 
after treatment of hepatoblastoma. choledochal cyst. scle-
rosing cholangitis. a,-antitrypsin deficiency, and type IV 
glycogen storage disease. The mean arterial pressure was 
.::tlculated as one third of the pulse pressure plus the 
diastolic pressure. No patient had preoperative hyperten-
sion or hypotension (defined as a calculated ~Am >90tb 
or < I Oth percentile for age)," renal dysfunction (abnormal 
blood urea nitrogen and serum creatinine values for age). 
or beart disease (abnormal chest radiograph and abnormal 
findings on physical examination). A baseline blood pres-
sure was obtained with a sphygmomanometer before 
arrival of each patient in the operating room. 
The perioperative period was divided into six periods for 
the purpose of blood sampling and postoperative collection 
of urine: induction of anesthesia. the anbepatic phase. 
reperfusion after rcvascularization of the donor liver. 
arrival in the intensive care unit. 24 hours postoperatively, 
and 48 bours postoperatively. 
General anesthesia was induced witb atrOpine and 
fentanyl. and neuromuscular relaxation was obtained with 
pancuronium. Anestbesia was maintained during surgery 
by nitrous oxide. oxygen. isofturane. and morphine. Seu-
romusc:ular blockade was maintained with pancuronium or 
atracurium. After induction of general anesthesia. an 
arterial catheter, a central venous catheter. and a urinary 
catheter were inserted for routine monitorinl throughout 
the study. 
At the beginning of each of the six periods. an anerial 
blood sample was drawn for determinatiOfl of serum 
osmolarity and of :uginine vasopressin. atrial natriuretic 
factor. blood urea nitrogen. creatinine. and sodium concen-
trations. Plasma renin activity was determined on arrival 
of the patient in the intensive care unit. and at :!4 hours 
and 48 hours postoperatively. Plasma cyclosporine concen-
tration was determined at 24 and 48 hours postoperatively. 
During the postoperative 0 to 24-hour and 24 to 48-hour 
periods. urine was collected for determinatiOfl of sodium 
and cre:ltinine concentrations and osmolarity. During the 
first 24 hours postoperatively, urine was collected (in '6:'11 
hydrochloric acid) from six of the patienu for determina-
tion of norepinephrine excretion. 
Sodium, creatinine. and blood urea nitrO&C1I co""ntra-
tions and osmoiarity W(tc measured by standard laborato-
ry techniques. Plasma renin activity was measured by 
radioimmunoassay of generated angiotensin I. Cyclospo-
rine. ANF, and A VP were measured by radioimmunoas-
say. Uri nay norepinephrine was assayed by bigh-perfor-
manee liquid chromatography. 
Postoperative bypertension or hypotension was defined 
as a calculated M:AP greater than the 90th or less than the 
10th percentile for age. I. .... II A normal A:-.IF concentra-
tion was 25 to 77 pg/ml. Vasopressin c:on<:enuations were 
interpreted in terms of serum osmolarity;': if the serum 
was hypotonic. an AVP concentration <I palmi was 
considered normal: if the serum was normotonic or hyper-
tonic. any AVP value >2 palmi was abnormal: and a 
concentration of >6 pgl ml at any time represented a 
npnpbysiologic: stimulation of A VP. A concClnration of 
>2.0 ng/ml/hr was considered abnormal. Our laboratory 
does not report a normal range for urinary noncpinephrine 
concentration for pediatric patienu: previously published 
age-adjusted norepinephrine values were used for compar-
ison.'''· 
The patient'S weight was recorded preoperatively, on tbe 
patient'S arrival in the intensive care unit. and at 24 and 48 
hours postopentively. During each period the central 
venous pressure was continuously monitored and ftuid 
therapy was adjusted to maintain a centnJ vCftOUS pressure 
of 4 to 10 mm Hg. There was continuous monitori .. of 
mean. systolic::, and diastolic anerial blood pressures. 
Hypertension was treated with antihypcrtemive agenu 
(nitroprusside. bydralazine. labetalol. c:aptopril. Of nifedi-
pine) or diuretics (furosemide) if tbe bypenensioll W. 
sustained for more tban 15 minutes despite appropriate 
analgesia. Two patienu had been treated witb furosemide 
preoperatively as pan of the management of ucites. 
However. once anesthesia was induced. none of the 
patienu rcc:cived antihypertensive a,C1Iu Of diuretics 
before the onset of hypertension. e~lDltensilll with a 
central pressure of <4 mm Hg and tachycudia was trcued 
with colloid or. if the hematocrit was <!S'lI. with packed 
erythrocytes. ~ethylprednisoloneK 20 to 30 mil kg. and 
cyclosporine. 2 to 3 mgikg. were administered intrave-
nously immediately after the donor liver was revascular-
izcd. Postoper.llively. methylprednisolone was pn on the 
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Fig. 1. Changes in pluma AVP concentration during operative (induction. anhepatic. and reperfllsion) and postopera· 
tive (arrival in intensive care unit. at 24 houts. and at 48 hoon) time points of study. 'p <0.05. 
first day in a dose of 2 mg/kg and on the second day in a 
divided dose of I mg/kg. Postoperatively. cyclosporine 
dosage was adjusted to maintain plasma trough concentra-
tions of 500 to 700 ng/ml. 
Renal function was evaluated by (I) the :4-hour deter-
mination of creatinine excretion index (calculated as the 
24-hour collected urinary creatinine divided by the weight. 
and expressed as milligrams of creatinine per kilogram per 
da~sf; (2) 24-hour creatinine clearance (calculated as 
follows: [Urinary creatinine/Serum creatinine] X [Urine 
volume/Total minutes of the collection] corrected to 1.73 
m:); (3) fractional excretion of sodium; (4) osmolar 
clearance (calculated as follows: [t; rine osmolarity/ Plas-
ma osmolarity] x [Urine volume/Unit time]); (5) free 
water clearance (calculated as follows: [Urine volume/ 
t.;nit time] - Osmolar clearance); (6) serum creatinine 
concentration: and (7) blood urea nitrogen concentration. 
The creatinine excretion index has been used as an aid in 
identifying renal insufficiency (low glomerular filtration 
rate) in patients with cirrhosis who have normal serum 
creatinine values.ll.Zl 
Statistical analysis was performed with the use of 
nonparametric tests.ll.:' The Friedman statistic was used 
to determine differences in group means over mUltiple 
periods. and the differences in group means between 
periods were analyzed by the Wilcoxon signed-rank sum 
test. Correlation between variables was established with 
the Spearman rank correlation coefficient. The relation-
ship of PRA and the creatinine excretion index was 
analyzed by the Fisher uact Test. Values arc represented 
as mean +/- SEM. Significance was defined as p 
<0.05. 
) 
RESULTS 
Hypertension developed in all nine patients but in only 
seven during the study period. In all p:nients. hypcnension 
developed while the central venous pressure was < 1 0 mm 
Hg. The onset of hypenension occurred after donor liver 
reperfusion in three patients and within 12 hours postoper-
atively in four patients. Two patients experienc=1 severe 
hemorrhage and hypotension post~perativelyK and only 
after reoperation to control bleeding did hypcnension 
develop (after the 48-hour postoperative period). In all 
patients. hypertension was sustained after onse: and was 
treated with multiple antihypenensive agents in combina-
tion with diuretics. 
All patients maintained a negative water clearance 
throughout the postoperative period. The serum creatinine 
concentrations postoperatively ranged from 0.1 to 1.2 
mg/dl (10 to 110 "mol/L). The fractional excretion of 
sodium ranged from 0.2% to 2.0% in the postoperative 
period. There were no correlations among cbange in 
central venous pressure. weight change. osmolar clearance. 
frcc water clearance. creatinine excretion index. or creau· 
nine clearance. 
There was a significant and non physiologic increase in 
A VP during the an hepatic and donor reperfusion periods 
(the periods of massive tluid shifts and blood 1055)13 and 
then a return to normal with the onset of hypcnension 
(Fig. I). This rise of A VP was not related to any change In 
serum osmolarity or central venous pressure. During the 
postoperative periods. A VP concentration changed appro-
priately with changes in serum and urine osmolarity." 
The mean plasma concentr:1tion of ANF (FiC. 2) was 
normal at induction of anesthesia and decreased during 
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Fig. 2. Changes in ANF concentration and percent change from preoperative baseline ~Am during operative 
(induction. anhepaLi<:.. and reperfusion) and postoperative (arrival in intensive care unit..lt 24 houn. and at 48 hounl time 
poinu of study . • p <O.OS. 
those periods of massive blood loss and fluid shifts associ-
ated with tbe rise in plasma A VP concentration. but then 
increased significantly (p <0.05) postoper:ltively with the 
onset of hypertension. This incrC3sc occurred during a 
period of relative fluid homeostasis and after the adminis-
tration of corticosteroids and cyclosporine. There was no 
significant correlation between AN F and postoperative 
renal function (urine output. creatinine excretion index. 
crC3tinine clearance. blood urC3 nitrogen level. fractional 
excretion of sodium. osmolar clearance. free water cle:u-
ance) or fluid balance. 
At the same time that the MAP was rising significantly 
and hypertension developed. the plasma concentration of 
A VP decreased (Fig. I) and the plasma concentration of 
ANF increased (Fig. 2). There was a significant (p <0.03) 
correlation between the increase in MAP from baseline 
lnd the increase in A:"jF oyer time. 
In those patientS with marginal renal function (crcui-
nine excretion index <12 mg(I06O j.£moIJ/kg/day).:a the 
PRA was significantly elevated (p <0.003). None of the 
patientS with a normal creatinine excretion index had an 
elevated PRA (Fig. J). 
In the six patientS in whom urinary norepinephrine 
excretion was mC3surcd. there was no significant elcv:uion 
(range 10 10 75 gAU/:!~ hr) in comparison with the· 
published normal age· adjusted range of norepinephrine 
.:xcrction.''':' There was no rel:uionship between .:xcretion 
of norepinephrine and tbe volume status. renal function. 
scverity of bypertension. or penistent hemorrhage. 
The mC31l plasma cyclosporine concentration 24 hours 
postoperatively was 695 ng/ml (range 253 to 1027 ngimi). 
The mean plasma cyclosporine concentration ~U boun 
postoperatively was S55 ns/ml (range 525 to 1135 ng ml). 
There was no correlation between the cyclosporine concen· 
tration and the severity of hypertension. renal function. or 
ftuid status. 
DISCUSSION 
The underlying hemodynamic abnormalities of severe 
hepatic dysfunction frequently include a high cardiac 
index and low systemic vascular resistance. Despite the low 
systemic vascular resistance. blood How and oxygen deliv-
ery to actively respiring tissues. such as the kidne~sK are 
low. probably because arteriovenous shunting produces 
organ hypoperfusion.:1·!1 This profound vasodilation 
resultS in. simultaneous total body ftuid overload but 3. 
margin3.1 circulatory volume. Restoration and mainte-
nance of this decreased "effective circulatory voiume" 
result from the interaction of vasoregulatory hormones 
and substances that regulate renal handling of salt and 
ftuid. :foo)1 Included in this regulation are the renin·angie-
tensin-aldosterone system. the sympathetic nervous sys-
tem. AVP. ANF. and prostaglandins.:'·'l.)1 
The liver transplant rec:ipient undergoes massive ~rie­
perative shiftS in fluids lnd hemodynamics. The usual 
operative course is characterized by the turnO'er of 
between 0.6 and 25 blood volumes. II. Jo Although patientS 
rarely evidence gross hypervolemia or hypovolemlOl at 
completion of surgery, the prec:isc intravascular blood 
volume in the immediate recovery period is not luwwn. In 
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addition. it is not currently known how effective the newly 
transplanted liver metabolizes endogenous vasoactive sub-
stancesKltK~ Indeed. the physiologic adaptations to cbronic 
liver failure will be markedly altered by tbe posuran$plant 
circulatory environment.17.11 
Vasopressin is released in response to dehydration. salt 
administration. hypotension. and surgical stressK-~ Atrial 
distension. not increased atrial pressure. and acute but not 
chronic salt loading lead to increased circulating ANF.41 ... 
Certain anesthetic agents and bi~ doses of narcotics also 
stimulate AN F release:' but neither the type of anesthetic 
agents. the doses of narcotic administered. nor any of the 
diuretics. antihypenensive drugs. nor immunosuppressive 
agents administered to the study patients have been shown 
to raise the plasma ANF concentration .... ,. 
The release of A VP and of A~c are inversely related. 
with no inhibiting interaction.'! We bave demonstrated 
this relationship in these patients.. During the intraopera-
tive phase. the plasma A VP concentration incrc:ascd in 
response to stress and hemorrhage but then dcaeased as 
the intravascular volume b«:ame more stable. The ANF 
concentration decreased in response to decreased intravas-
cular volume but then increased when the patients had a 
significant rise in blood pressure from their preoperative 
baseline and became hypenensive. 
We did not determine cardiac output or blood volume. 
but the postoperative increase in ANF concentration and 
decrease in A VP concentration suuest that these patients' 
blood volume or salt load. or both. had acutely increased 
despite an unchanged central venous pressure. lO Patients 
with cirrhosis already have a positive sodium balance." In 
addition. conicosteroid administration increases salt reten-
tion in these patients. Large doses of methlyprednisolone 
exen a significant mineraloconicoid effect. wich is funher 
compounded by dcaeascd hepatic blood flow.S' The high 
salt content of administered blood products funher 
increases the circulatory load in these patients. 
Whether the change in the plasma conc:cntration of 
AN F is physiologically signilicant could not be deter-
mined. bat there was no significant decrease in blood 
pressure. increase in fractional excretion of sodium, or 
increase in frcc water clearance associated with the rise in 
ANF levds. 
The elevated PRA at a time of fluid overload or salt 
overload. or both. indicates that some of the patients ma~ 
have been in a hyperrenincmic state. Although diuretic and 
antihypenensive agents can elevate PRA. the elevated 
PRA in our patients W85 demonstrated before these agents 
were administered. A low creatinine excretion index « 12 
mg/kg/day),» and thus a low glomerular filtration rate. 
may serve as a marker (or an elevated PRA. The c;reatinine 
excretion index may give a better indication of impaired 
glomerular function tban calculated creatinine clearance 
givesK~1 An impaired liver may not be able to conven 
muscle creatine to creatinine optimally. In addition. 
patients in a poor nutritional state may not have significant 
••• ilAlHr 115 
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erc:! tine stores. Both of these factors could result in a low 
~rum creatinine concentration. which would also falsely 
dev:ue the calculated creatinine c1earance.!u, 
The effect of cyclosporine on the early hemodynamic 
,tatus of liver transplant recipients is not entirely clear. 
Postoperative hypertension can occur in pediatric patients 
after liver transplantation if they are not treated with 
cyclosporine.! Hypertension develops in many patients who 
receive cyclosporine either for transplantation or for 
immunosuppression without transplantation.""'" Howev-
er. despite the use of similar or higher doses of cyclospo-
rine.'"'· sa the hypertension that develops in patients recciv-
:ng cyclosporine as part of their non-liver· transplantation 
Immunosuppression is less acute and less severe tban the 
h)pertension that initially occurs after liver transplanta-
tion.'·11 
In our pateints the cyclosporine plasma concentrations 
were therapeutic after the initial dose. A cyclosporine 
infusion can acutely cause renal vasoconstriction mediated 
by the sympathetic nervous system-1 and can also lead to 
S<lCiium and water retention. IUJ This renal vascular effect 
<If cyclosporine could partially account for the inadequate 
:latriuretic and diuretic response to the elevated ANF 
K;on~ntrations after liver transplantation. The chronic 
hYJ)Crtension that develops in patients receiving cyclospo-
rine is attenuated by salt restriction." 
The urinary norepinephrine excretion. rather than the 
plasma norepinephrine concentration. was chosen as a 
marlcer of sympathetic tone in the immediate 24-hour 
postoperative period. The plasma norepinephrine concen-
tration docs not consistently reHeet sympathetic activity in 
human beings because of a wide range and variability in 
plasma concentrations'" and may be less reHective of 
norepinephrine turnover than urinary norepinephrine 
excretion .... ., The urinary norepinephrine excretion values 
obtained could reflect a significant stimulation of the 
sympathetic nervous system by either cycJosporine or 
stress. but there are few pubiished normal values of 
age·specific urinary catecholamine excretion and no previ-
<lusly published reference values for pediatric patients who 
have undergone liver transplantation.'ao. 
The data from our study indicate that the perioperative 
course of liver transplantation is char:acterized by massive 
fluid shifts. which result in a transition from a central 
hyperdynamic state of normal or low blood pressure. with 
IlUrginal organ perfusion. to a st:lte of volume overload 
and acute severe systemic hypertension. The physiologic 
mechanisms regulating A VP and AN F release attempt to 
effect a normal adjustment to intrav:lSCul:u hypervolemia 
and acute salt overload. The kidney, however. cannot 
compensate with an appropriate diuresis or natriuresis. for 
a variety of rc:LSOns. such as :I high PRA in patienu with 
H.I'l'rrtrrulUn during ,In" IJjlrr li'·f!r ITUIIlPIuntUlIlJ1I 377 
impaired renal function and the effects of cyclosporine and 
steroids. The hypertension that develops in patients :lfter 
liver transplantation appears to be multifactorial and may 
i.nvolvc a relative salt :lnd volume overload in conjunction 
. with absence of a diuretic or natriuretic response by the 
kidney to these loads. Although many or the hormonal 
changes and renal responses observed may reflect our 
specific perioperative management. we recommend that 
the treatment of the acute hypenension that develops after 
pediatric orthotopic liver transplantation include restricted 
salt intake. the use of diu retia. and. in those patients with 
a decreased creatinine excretion index. the use or angioten-
sin converting enzyme inhibitors. 
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